-
09/08/2017
Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2018
-
08/09/2017
Year Ending March 31, 2018 Results of 1st Quarter Settlement of Accounts Supplementary Material (Apr.1 to Jun.30 2017)
-
07/13/2017
Licensing Agreement for Marketing Rights to Infliximab BS for I.V. Infusion 100mg “AYUMI”
-
06/19/2017
Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
読む Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
-
05/30/2017
Notice of the 53rd Ordinary General Meeting of Shareholders
読む Notice of the 53rd Ordinary General Meeting of Shareholders
